Cardio Diagnostics Holdings Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.401
- Today's High:
- $0.4844
- Open Price:
- $0.43
- 52W Low:
- $0.797
- 52W High:
- $10.25
- Prev. Close:
- $0.42
- Volume:
- 180560
Company Statistics
- Market Cap.:
- $14.47 million
- Book Value:
- 0.356
- Revenue TTM:
- $950
- Operating Margin TTM:
- -633581.54%
- Gross Profit TTM:
- $901
- Profit Margin:
- 0%
- Return on Assets TTM:
- -80.17%
- Return on Equity TTM:
- -257.3%
Company Profile
Cardio Diagnostics Holdings Inc had its IPO on 2022-01-14 under the ticker symbol CDIO.
The company operates in the Healthcare sector and Biotechnology industry. Cardio Diagnostics Holdings Inc has a staff strength of 7 employees.
Stock update
Shares of Cardio Diagnostics Holdings Inc opened at $0.43 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.4 - $0.48, and closed at $0.44.
This is a +5.81% increase from the previous day's closing price.
A total volume of 180,560 shares were traded at the close of the day’s session.
In the last one week, shares of Cardio Diagnostics Holdings Inc have slipped by -17.7%.
Cardio Diagnostics Holdings Inc's Key Ratios
Cardio Diagnostics Holdings Inc has a market cap of $14.47 million, indicating a price to book ratio of 1.6376 and a price to sales ratio of 13622.657.
In the last 12-months Cardio Diagnostics Holdings Inc’s revenue was $950 with a gross profit of $901 and an EBITDA of $-6002240. The EBITDA ratio measures Cardio Diagnostics Holdings Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Cardio Diagnostics Holdings Inc’s operating margin was -633581.54% while its return on assets stood at -80.17% with a return of equity of -257.3%.
In Q1, Cardio Diagnostics Holdings Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 5.4%.
Cardio Diagnostics Holdings Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.54 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cardio Diagnostics Holdings Inc’s profitability.
Cardio Diagnostics Holdings Inc stock is trading at a EV to sales ratio of 6914.0888 and a EV to EBITDA ratio of -4.4874. Its price to sales ratio in the trailing 12-months stood at 13622.657.
Cardio Diagnostics Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $8.55 million
- Total Liabilities
- $4.39 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $52674
- Dividend Payout Ratio
- 0%
Cardio Diagnostics Holdings Inc ended 2024 with $8.55 million in total assets and $0 in total liabilities. Its intangible assets were valued at $8.55 million while shareholder equity stood at $3.42 million.
Cardio Diagnostics Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $4.39 million in other current liabilities, in common stock, $-7024164.00 in retained earnings and $0 in goodwill. Its cash balance stood at $6.71 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
Cardio Diagnostics Holdings Inc’s total current assets stands at $8.14 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $0 and inventory worth $0.
In 2024, Cardio Diagnostics Holdings Inc's operating cash flow was $0 while its capital expenditure stood at $52674.
Comparatively, Cardio Diagnostics Holdings Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.44
- 52-Week High
- $10.25
- 52-Week Low
- $0.797
- Analyst Target Price
- $8
Cardio Diagnostics Holdings Inc stock is currently trading at $0.44 per share. It touched a 52-week high of $10.25 and a 52-week low of $10.25. Analysts tracking the stock have a 12-month average target price of $8.
Its 50-day moving average was $0.9 and 200-day moving average was $1.83 The short ratio stood at 0.73 indicating a short percent outstanding of 0%.
Around 3641.2% of the company’s stock are held by insiders while 370.6% are held by institutions.
Frequently Asked Questions About Cardio Diagnostics Holdings Inc
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
Cardio Diagnostics Holdings, Inc., an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago, Illinois.